13F HOLDINGS REPORT
RiverVest Venture Management LLC
Quarter ended Q3 2023 · Filed August 7, 2023 · Accession 0001104659-23-088192
Total Value
$90.2M
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Mirum Pharmaceuticals, Inc. | MIRM | 1,621,118 | $41.9M | 46.52% |
| 2 | Allakos, Inc. | 01671P100 | 4,887,932 | $21.3M | 23.64% |
| 3 | Reneo Pharmaceuticals, Inc. | 75974E103 | 2,534,220 | $16.6M | 18.44% |
| 4 | Spruce Bioscience, Inc. | SPRB | 2,936,281 | $6.3M | 7.00% |
| 5 | Xilio Therapeutics, Inc. | XLO | 1,441,444 | $3.8M | 4.19% |
| 6 | Vapotherm, Inc. | 922107107 | 417,808 | $188,014 | 0.21% |